CSI Market
Sign In | Register

23andme Holding Co (ME) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ME quarterly Cash Flow →
This page allows investors to follow 23andme Holding Co's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Mar 31 2025)
12 Months 		(Mar 31 2024) (Mar 31 2023) (Mar 31 2022)
Operating Activities
Income-280.89
Depreciation & amortization14.32
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Impairment of Long-Lived Assets to be Disposed of60.40
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-3.09
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-0.37
Share-based Compensation62.03
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Amortization And Impairment Of Internal Use Software9.04
Increase Decrease In Deferred Cost Of Revenue-0.38
Increase Decrease In Operating Lease Right Of Use Assets6.64
Increase Decrease In Contract With Customer Liability1.42
Increase Decrease In Operating Lease Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable1.97
Increase (Decrease) in Accounts Payable-5.77
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities0.67
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.16
Other Working Capital-3.15
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-33.57
Discontinued operations0.00
Net Cash flow from Operating Activities-169.59
Investing Activities
Capital Expenditures-6.86
Sale of Capital Items3.16
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-3.70
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.67
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-238.71
Proceeds From Sale Of Units Net Of Underwriting Discounts Paid-
Payments Of Deferred Offering Costs-
Vesting Early Exercised Stock Options-
Assumption Of Merger Warrants Liability-
Deferred Offering Costs During The Period Included In Accounts Payable And Accrued Expenses-
Conversion Of Redeemable Convertible Preferred Stock To Common Stock-
Reconciliation Of Cash And Restricted Cash Within The Consolidated Balance Sheets To The Amounts Shown In The Consolidated Statements Of Cash Flows Above-
Restricted Cash Current7.75
Restricted Cash Noncurrent5.30
Payments For Taxes Related To Net Share Settlement Of Equity Awards-0.15
Proceeds From Exercise Of Stock Options-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents224.86
Purchases Of Property And Equipment During The Period Included In Accounts Payable And Accrued Expenses-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.28
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-173.29
Total Cash Flow-173.57
4 historic quarters locked

Sign in to unlock the full 23andme Holding Co cash flow history.

Sign In Create Free Account

About 23andme Holding Co Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-25-030786

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License